N/A
Completed N=7,387
Increasing Optimal Use of HPV Vaccination in Primary Care
Human Papillomavirus Vaccines
Source: ClinicalTrials.gov NCT04180462 ↗
Enrolled (actual)
7,387
Serious AEs
0.0%
Results posted
Feb 2024
Primary outcomePrimary: Initiation of the HPV Vaccine 2-dose Series. — 1723; 1219 Participants
Summary
Washington University will evaluate the effectiveness of a multi-component implementation strategy to increase use of HPV vaccine in primary care practices.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Initiation of the HPV Vaccine 2-dose Series. |
1723; 1219 | — |
| PRIMARY Completion of the HPV Vaccine 2-dose Series. |
1135; 809 | — |
| SECONDARY Sustainability of the Intervention Benefit for Initiation of the HPV Vaccine. |
1812; 1052 | — |
| SECONDARY Sustainability of the Intervention Benefit for Completion of the HPV Vaccine. |
1279; 703 | — |
Eligibility Criteria
Inclusion Criteria
Practices:
- Community-based pediatric primary care practices with 2 or more providers.
- Providers who deliver wellness care to preteens and adolescents.
- Willingness to participate in the practice facilitator-guided QI process.
Providers:
- Providers who deliver wellness care to preteens and adolescents.
- Willingness to complete study questionnaires.
- Willingness to participate in the practice facilitator-guided QI process.
EXCLUSION CRITERIA
- Practices and providers may be excluded at the discretion of the PI.
Data sourced from ClinicalTrials.gov (NCT04180462). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.